420% Organic Visibility Growth in Pharmaceuticals
How we helped a pharmaceutical company dominate YMYL search results through compliant content strategy, technical SEO, and medical-grade E-E-A-T authority building.
The Challenge: YMYL Compliance Meets Competitive Rankings
Pharmaceutical SEO operates under the strictest scrutiny of any industry. Google classifies health and medical content as Your Money or Your Life (YMYL), meaning factual inaccuracies or misleading claims trigger aggressive algorithmic penalties. Beyond Google's requirements, pharma companies must comply with FDA advertising guidelines, making every content decision a balancing act between SEO optimization and regulatory compliance.
Our client — a mid-market pharmaceutical company — had strong products but weak digital presence. Their website was technically sound but content-anemic: product pages with minimal copy, no educational content, no structured data, and zero thought leadership positioning.
The Strategy: Compliant Content at Scale
Medical Review Workflow
Built a content pipeline with integrated medical/legal review. Every piece of content was reviewed by a PharmD before publication, with E-E-A-T author bios and credential links.
Condition-Based Content Hubs
Created comprehensive content hubs for each therapeutic area: condition overview, treatment options, clinical data summaries, patient resources — all interlinked with pillar-cluster architecture.
Technical SEO Overhaul
Implemented MedicalWebPage schema, fixed crawl budget waste from PDF-heavy product documentation, and optimized Core Web Vitals across a legacy CMS.
HCP vs. Patient Content Split
Segmented content by audience (healthcare professionals vs. patients) with distinct URL structures, vocabulary levels, and schema markup — capturing both search intents without confusing either audience.
Compliance as a competitive advantage
FDA Compliant
All claims substantiated per FDA advertising guidelines
PharmD Reviewed
Every page reviewed and signed off by licensed pharmacist
Citations Verified
Clinical data linked to PubMed, ClinicalTrials.gov sources
Most pharma companies treat compliance as an obstacle to SEO. We treated it as a moat. By building the medical review workflow into our content pipeline from day one, we produced content that competitors — who often cut corners on sourcing and review — couldn't match. Google's E-E-A-T algorithms rewarded this rigor.
Keyword Rankings: Capturing Both Patient and HCP Searches
| Keyword | Position | Volume | Audience |
|---|---|---|---|
| [condition] treatment options | 2 | 8,100 | Patient |
| [drug class] mechanism of action | 1 | 2,400 | HCP |
| [condition] symptoms and causes | 3 | 12,100 | Patient |
| [drug name] vs [competitor drug] | 1 | 1,900 | Both |
| [condition] clinical guidelines 2026 | 4 | 1,300 | HCP |
| [drug name] side effects | 2 | 6,600 | Patient |
| [condition] new treatments | 5 | 4,400 | Patient |
| [drug class] prescribing information | 3 | 880 | HCP |
Organic Visibility Growth
SEMrush Visibility Index — 18-Month Trend
Traffic by Content Type
Organic Traffic Distribution by Content Category
Key Results
Industry Deep Dive
Healthcare SEO: The Complete Industry Guide
Explore the full analysis — patient search behavior, YMYL compliance, AI Overviews impact, local SEO strategy, and ROI benchmarks across every healthcare vertical.
Read the Full Healthcare SEO Guide →Need YMYL-Compliant SEO for Pharma?
Our team understands the intersection of medical content, regulatory compliance, and search engine optimization.
Get Your Free SEO Audit →